| |
|
|
|
VAL 3: Commissioning and Installation Qualification
Description: An introduction to the international regulations and principles behind Commissioning and Installation Qualification.
Price: $259 (AUD)
|
 |
(Australian customers, please add GST.)
Note: We use 128-bit SSL security encryption on all webpages where private information is taken.
Terms and conditions
|
|
COURSE OUTLINE
OUTCOMES
1. Introduction
2. First Class Pharmaceuticals
3. Meet the V Team
4. The new line
5. Regulatory definitions
6. Guidance docuements
7. V model approach
8. Summary
DEFINITIONS
9. Introduction
10. Common interfaces
11. Commissioning/IQ timeline
12. Purpose of commissioning
13. Purpose of IQ
14. Comparisons
15. Review I
16. FAT and SAT
17. Responsibilities
18. Vendor Responsibilities
19. Commissioning reports
20. Summary
21. Review II
IMPACT ASSESSMENTS
22. Introduction
23. Levels of impact
24. System boundaries I
25. System boundaries II
26. The impact assessment
27. Criticality assessment
28. Determining criticality
29. Assessment flowchart
30. Review I
31. The scope of activity
32. Summary
33. Review II
SCOPE OF IQ
34. Introduction
35. Essential IQ items
36. Test requirements
37. Calibration requirements
38. Review I
39. Summary
40. Review II
IQ PROTOCOLS
41. Introduction
42. Approval of IQ report
43. Conducting the IQ
44. Documentation
45. Summary
46. Review
CONCLUSION
47. Summary
|
|
COURSE OBJECTIVES
Students completing this course should be able to:
- Define installation qualification and commissioning activities
- Explain the difference between qualification and commissioning
- Determine qualification requirements based on an impact/risk assessment
- State and explain the scope and responsibilities of IQ
- Prepare and execute an IQ protocol
- Prepare and approve an IQ report
|
|
|
|

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.
|
|